UBS Group’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $599K | Sell |
|
|||||
|
2025
Q1 | $722K | Sell |
|
|||||
|
2024
Q4 | $1.41M | Buy |
|
|||||
|
2024
Q3 | $1.36M | Buy |
|
|||||
|
2024
Q2 | $1.23M | Sell |
|
|||||
|
2024
Q1 | $2.39M | Buy |
|
|||||
|
2023
Q4 | $2.05M | Buy |
|
|||||
|
2023
Q3 | $513K | Sell |
|
|||||
|
2023
Q2 | $2.45M | Buy |
|
|||||
|
2023
Q1 | $2.81M | Sell |
|
|||||
|
2022
Q4 | $3.93M | Buy |
|
|||||
|
2022
Q3 | $456K | Sell |
|
|||||
|
2022
Q2 | $1.08M | Sell |
|
|||||
|
2022
Q1 | $3.49M | Buy |
|
|||||
|
2021
Q4 | $2.89M | Buy |
|
|||||
|
2021
Q3 | $343K | Sell |
|
|||||
|
2021
Q2 | $1.12M | Sell |
|
|||||
|
2021
Q1 | $1.5M | Buy |
|
|||||
|
2020
Q4 | $350K | Buy |
|
|||||
|
2020
Q3 | $23K | Buy |
|